BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20044267)

  • 1. Preoperative radiochemotherapy for resectable localised oesophageal cancer: a controversial strategy.
    Crehange G; Bonnetain F; Peignaux K; Truc G; Blanchard N; Rat P; Chauffert B; Ghiringhelli F; Maingon P
    Crit Rev Oncol Hematol; 2010 Sep; 75(3):235-42. PubMed ID: 20044267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Place of neoadjuvant treatments in oesophageal cancers care].
    Créhange G; Lorchel F; Bosset JF
    Bull Cancer; 2006 Nov; 93(11):1107-13. PubMed ID: 17145580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal treatment for localized esophageal cancer still uncertain.
    Lord RV
    Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
    Chao YK; Wu YC; Liu YH; Tseng CK; Chang HK; Hsieh MJ; Chu Y; Liu HP
    J Surg Oncol; 2010 Aug; 102(2):158-62. PubMed ID: 20648587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus.
    Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC
    Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemoradiotherapy for advanced esophageal cancer].
    Natsugoe S; Matsumoto M; Okumura H; Uchikado Y; Setoyama T; Kita Y; Arigami T; Uenosono Y; Owaki T; Ishigami S
    Nihon Geka Gakkai Zasshi; 2011 Mar; 112(2):111-6. PubMed ID: 21488344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?
    Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):661-4. PubMed ID: 17670718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to definitive chemoradiotherapy and survival in patients with an oesophageal adenocarcinoma versus squamous cell carcinoma: a matched-pair analysis.
    Tougeron D; Di Fiore F; Hamidou H; Rigal O; Paillot B; Michel P
    Oncology; 2007; 73(5-6):328-34. PubMed ID: 18497505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal cancer: adjuvant therapy.
    Ku GY; Ilson DH
    Cancer J; 2007; 13(3):162-7. PubMed ID: 17620765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.
    Geh JI; Crellin AM; Glynne-Jones R
    Br J Surg; 2001 Mar; 88(3):338-56. PubMed ID: 11260097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma of the esophagus: multimodal therapy in locally advanced disease.
    El Nakadi I; Van Laethem JL; Houben JJ; Gay F; Closset J; Van Houtte P; Danhier S; Limbosch JM; Lambilliotte JP; Gelin M
    World J Surg; 2002 Jan; 26(1):72-8. PubMed ID: 11898037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel?].
    Hölscher AH; Metzger R; Schneider PM
    Zentralbl Chir; 2000; 125(4):319-25. PubMed ID: 10829311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
    Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
    J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.